Mark E. Bunnage

VRTX

Mark E. Bunnage serves as officer: EVP, Chief Scientific Officer at Vertex Pharmaceuticals Incorporated (VRTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$3.52M

Net Position

Net Seller

$3.52M

Companies Traded

VRTX

Active Period

Feb 2026

3 total trades

Most Recent

Sell VRTX

Feb 26, 2026 · $301.5K

Mark E. Bunnage's Insider Trading at Vertex Pharmaceuticals Incorporated (VRTX)

Buys

0 · $0.00

Sells

3 · $3.52M

Total Shares Bought

Total Shares Sold

7,370

VRTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 26, 2026	Sell	620	$486.35	$301.5K	7,284
Feb 17, 2026	Sell	4,729	$484.18	$2.29M	0
Feb 12, 2026	Sell	2,021	$460.43	$930.5K	12,914

Related Insiders

Joy Liu

officer: EVP and Chief Legal Officer

VRTXSell · Apr 3, 2026

Carmen Bozic

officer: EVP and CMO

VRTXSell · Mar 31, 2026

Duncan McKechnie

officer: EVP, Chief Commercial Officer

VRTXSell · Mar 13, 2026

Reshma Kewalramani

director, officer: CEO & President

VRTXSell · Mar 3, 2026

Kristen Ambrose

SVP & Chief Accounting Officer

VRTXSell · Mar 2, 2026

Ourania Tatsis

officer: EVP, Chief Reg. & Quality Off.

VRTXSell · Feb 26, 2026

Jonathan Biller

officer: EVP and Chief Legal Officer

VRTXSell · Feb 26, 2026

Edward Morrow Atkinson III

officer: EVP, Chief Technical Ops. Off.

VRTXSell · Feb 26, 2026

Explore More Insider Trading Data

VRTX Insider Trading Activity

View all insider trades at Vertex Pharmaceuticals Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity